On September 21, 2026, Henry Schein, Inc. entered into the Fourth Amended and Restated Revolving Credit Agreement, increasing its aggregate revolving credit commitments from $1 billion to $1.25 billion. The amendment extends the termination date to September 19, 2031 and modifies certain financial definitions and covenants. Proceeds will support working capital, general corporate purposes, capital expenditures, stock repurchases, debt refinancing, and potential acquisitions. This is a significant financing update for Henry Schein, Inc., which distributes health care products and provides business management services to dental, medical, and veterinary professionals.
